Skip to main content
Premium Trial:

Request an Annual Quote

Stratagene Shares Rise on Agilent Acquisition Pact

Shares in Stratagene rose 28.8 percent for the four-day trading week ended Tuesday after Agilent signed a deal to buy the firm for $10.94 a share (see related article this issue). The acquisition price represents a 28 percent premium over Stratagene’s closing price the day before the deal was announced.
 
Stratagene led all gainers for the week. Shares in Third Wave Technologies registered the second-biggest increase for the tracking period, rising 10.6 percent.
 
Beckman Coulter led the four firms that declined for the week. Shares in the firm dropped 3 percent after Inverness Medical Innovations made a rival acquisition bid for Biosite.
 
Overall, the BCW Index gained 1.2 percent for the trading week, which was a day shorter due to the Good Friday holiday. The Dow Jones Industrial Average was up .5 percent, the Nasdaq rose 1.1 percent, and the Nasdaq Biotech Index gained 2.6 percent for the week.

 
 
 

 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Closing Price (April 10, 2007)
Starting Price
(
April 4, 2007)
% change
Affymetrix
AFFX
31.17
30.42
2.47
Agilent
A
34.91
34.55
1.04
Applied Biosystems
ABI
30.55
29.34
4.12
Beckman
BEC
63.81
65.76
-2.97
Becton Dickinson
BDX
77.93
78.89
-1.22
Bio-Rad
BIO
70.36
69.99
0.53
Bruker
BRKR
10.65
10.57
0.76
Caliper
CALP
5.84
5.69
2.64
Cepheid
CPHD
11.62
11.47
1.31
Illumina
ILMN
31.56
29.5
6.98
Invitrogen
IVGN
65.39
63.99
2.19
Luminex
LMNX
13.92
13.9
0.14
MDS
MDZ
19.08
18.77
1.65
Millipore
MIL
73.11
72.61
0.69
PerkinElmer
PKI
24.6
24.44
0.65
Qiagen
QGEN
17.49
17.66
-0.96
Sequenom
SQNM
3.71
3.8
-2.37
Sigma-Aldrich
SIAL
42.19
42.11
0.19
Stratagene
STGN
10.7
8.31
28.76
Thermo
TMO
48.24
46.72
3.25
Third Wave
TWTI
5.86
5.3
10.57
Waters
WAT
59.75
59.52
0.39
BCW Index Average  
34.20
33.79
1.23
The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more